Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy
Epilepsia · 2025
DOI: 10.1111/epi.18427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Ingride Luzio Gaspar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmacology, Department of Neuroscience, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Epilepsy, KCNQ2 Potassium Channel, Spasms, Infantile. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Regione Campania, Ministero dell'Università e della Ricerca.
Abstract (Originalsprache)
De novo variants in KCNQ2 cause neonatal onset developmental and epileptic encephalopathy ( KCNQ2 ‐DEE; Online Mendelian Inheritance in Man #613720), most often by loss‐of‐function in vitro effects. In this study, we describe a neonatal onset DEE proband carrying a recurrent de novo KCNQ2 variant (c.794C>T; p.A265V) affecting the pore domain of KCNQ2 ‐encoded Kv7.2 subunits. Whole‐cell patch‐clamp measurement in a mammalian heterologous expression system revealed that, when compared to wild‐type Kv7.2 channels, channels containing Kv7.2 A265V subunits displayed (1) reduced maximal current density; (2) decreased voltage‐dependence of activation; and (3) an unusual inactivation process, with a 50% current reduction during 1–2‐s depolarizing pulses at voltages > 0 mV. These effects were proportional to the number of mutant subunits incorporated in heteromeric channels, being overall less dramatic upon coexpression with Kv7.2 or Kv7.2 + Kv7.3 subunits. These results reveal current inactivation as a novel pathogenetic mechanism for KCNQ2 ‐DEE caused by a recurrent variant affecting a critical pore residue, further highlighting the importance of in vitro functional assessment for a better understanding of disease molecular pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Pharmacology, Department of Neuroscience, University of Naples Federico II, Naples, Italy.
- International School of Advanced Studies, University of Camerino, Camerino, Italy.
- Section of Child Neuropsychiatry, Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
- Section of Medical Genetics, Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
- CEINGE Advanced Biotechnology, Naples, Italy.
ORCID-Profile: Ingride Luzio Gaspar, Gaetano Terrone, Giusy Carleo, Lidia Carotenuto, Francesco Miceli, Maurizio Taglialatela
Förderung
- Ministero della Salute
- Regione Campania
- Ministero dell'Università e della Ricerca
Zitieren
APA
Gaspar, I. L., Terrone, G., Carleo, G., Carotenuto, L., Miceli, F., De Vita, G., & Taglialatela, M. (2025). Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy. Epilepsia. https://doi.org/10.1111/epi.18427
Vancouver
Gaspar IL, Terrone G, Carleo G, Carotenuto L, Miceli F, De Vita G, et al. Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy. Epilepsia. 2025. doi:10.1111/epi.18427
BibTeX
@article{Gaspar2025,
author = {Gaspar, Ingride Luzio and Terrone, Gaetano and Carleo, Giusy and Carotenuto, Lidia and Miceli, Francesco and De Vita, Gabriella and Taglialatela, Maurizio},
title = {Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.18427}
}
EUVIMED